• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Do not blame the SSRIs: blame the Hamilton Depression Rating Scale.

作者信息

Østergaard Søren Dinesen

机构信息

Psychosis Research Unit,Department of Clinical Medicine,Aarhus University,Risskov,Denmark.

出版信息

Acta Neuropsychiatr. 2018 Oct;30(5):241-243. doi: 10.1017/neu.2017.6. Epub 2017 Mar 1.

DOI:10.1017/neu.2017.6
PMID:28245891
Abstract
摘要

相似文献

1
Do not blame the SSRIs: blame the Hamilton Depression Rating Scale.不要责怪选择性5-羟色胺再摄取抑制剂：责怪汉密尔顿抑郁量表吧。
Acta Neuropsychiatr. 2018 Oct;30(5):241-243. doi: 10.1017/neu.2017.6. Epub 2017 Mar 1.
2
Efficacy and safety of selective serotonin reuptake inhibitors in the treatment of depression in children and adolescents: practitioner review.选择性5-羟色胺再摄取抑制剂治疗儿童和青少年抑郁症的疗效与安全性：从业者综述
Clin Drug Investig. 2006;26(5):247-55. doi: 10.2165/00044011-200626050-00002.
3
Relative antidepressant efficacy of bupropion and the selective serotonin reuptake inhibitors in major depressive disorder: gender-age interactions.安非他酮与选择性5-羟色胺再摄取抑制剂治疗重度抑郁症的相对抗抑郁疗效：性别-年龄交互作用
Int Clin Psychopharmacol. 2007 Jul;22(4):226-9. doi: 10.1097/YIC.0b013e32819f8400.
4
Milnacipran and selective serotonin reuptake inhibitors in major depression.米那普明与选择性5-羟色胺再摄取抑制剂治疗重度抑郁症
Int Clin Psychopharmacol. 1996 Sep;11 Suppl 4:41-6. doi: 10.1097/00004850-199609004-00006.
5
Assessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitors.用希恩残疾量表评估度洛西汀与选择性5-羟色胺再摄取抑制剂治疗的重度抑郁症患者的功能转归。
Hum Psychopharmacol. 2016 Jan;31(1):53-63. doi: 10.1002/hup.2500. Epub 2015 Sep 1.
6
Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study.选择性5-羟色胺再摄取抑制剂及5-羟色胺与去甲肾上腺素再摄取抑制剂可改善部分缓解型抑郁症患者的认知功能：一项前瞻性观察队列研究的结果
CNS Neurol Disord Drug Targets. 2016;15(10):1290-1298. doi: 10.2174/1871527315666161003170312.
7
Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression.文拉法辛与选择性5-羟色胺再摄取抑制剂（SSRI）的疗效比较：抑郁症患者的汇总分析
Biol Psychiatry. 2002 Dec 15;52(12):1166-74. doi: 10.1016/s0006-3223(02)01425-7.
8
Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo.无抑郁天数作为重度抑郁症治疗中反应和缓解时间模式的汇总指标：文拉法辛、选择性5-羟色胺再摄取抑制剂与安慰剂的比较
J Clin Psychiatry. 2003 Mar;64(3):321-30. doi: 10.4088/jcp.v64n0315.
9
SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study.选择性5-羟色胺再摄取抑制剂不会加重帕金森病：一项开放标签前瞻性研究的证据。
Clin Neuropharmacol. 2001 Jul-Aug;24(4):221-7. doi: 10.1097/00002826-200107000-00005.
10
Factor analysis of electroacupuncture and selective serotonin reuptake inhibitors for major depressive disorder: an 8-week controlled clinical trial.电针和选择性 5-羟色胺再摄取抑制剂治疗重性抑郁症的因子分析：一项 8 周对照临床试验。
Acupunct Med. 2020 Feb;38(1):45-52. doi: 10.1136/acupmed-2017-011412. Epub 2019 Sep 23.

引用本文的文献

1
Association of pharmacodynamic genes with treatment outcomes in major depressive disorder: results from a Sardinian cohort.药效学基因与重度抑郁症治疗结果的关联：来自撒丁岛队列的结果。
Pharmacogenomics J. 2025 Apr 23;25(3):10. doi: 10.1038/s41397-025-00373-2.
2
Rasch analysis of a patient-reported outcome measure for self-perceived health among psychiatric patients in Denmark.丹麦精神科患者自我感知健康的患者报告结局测量的 Rasch 分析。
BMJ Open Qual. 2024 Feb 12;13(1):e002519. doi: 10.1136/bmjoq-2023-002519.
3
Impact of chosen cutoff on response rate differences between selective serotonin reuptake inhibitors and placebo.
所选临界值对选择性5-羟色胺再摄取抑制剂与安慰剂之间反应率差异的影响。
Transl Psychiatry. 2022 Apr 14;12(1):160. doi: 10.1038/s41398-022-01882-5.
4
On the Meaning of the " Factor" in Symmetrical Bifactor Models of Psychopathology: Recommendations for Future Research From the Bifactor-(-1) Perspective.对称双因素模型中“因素”的意义：来自双因素-（-1）视角的未来研究建议。
Assessment. 2023 Apr;30(3):487-507. doi: 10.1177/10731911211060298. Epub 2021 Dec 3.
5
Antipsychotic-placebo separation on the PANSS-6 subscale as compared to the PANSS-30: a pooled participant-level analysis.与阳性和阴性症状量表（PANSS）-30相比，PANSS-6分量表上抗精神病药物与安慰剂的分离情况：一项汇总参与者水平分析
NPJ Schizophr. 2021 Aug 27;7(1):41. doi: 10.1038/s41537-021-00168-x.
6
Do side effects of antidepressants impact efficacy estimates based on the Hamilton Depression Rating Scale? A pooled patient-level analysis.抗抑郁药的副作用是否会影响基于汉密尔顿抑郁评定量表的疗效评估？一项汇总的患者水平分析。
Transl Psychiatry. 2021 Apr 27;11(1):249. doi: 10.1038/s41398-021-01364-0.
7
Different cytokine patterns associate with melancholia severity among inpatients with major depressive disorder.在重度抑郁症住院患者中，不同的细胞因子模式与忧郁症严重程度相关。
Ther Adv Psychopharmacol. 2020 Sep 1;10:2045125320937921. doi: 10.1177/2045125320937921. eCollection 2020.
8
Electroconvulsive therapy (ECT) for moderate-severity major depression among the elderly: Data from the pride study.电抽搐治疗（ECT）治疗老年中度至重度重度抑郁症：来自骄傲研究的数据。
J Affect Disord. 2020 Sep 1;274:1134-1141. doi: 10.1016/j.jad.2020.05.039. Epub 2020 May 23.
9
One (effect) size does not fit at all: Interpreting clinical significance and effect sizes in depression treatment trials.一种效应大小并不完全适用：解读抑郁症治疗试验中的临床意义和效应大小。
J Psychopharmacol. 2020 Oct;34(10):1074-1078. doi: 10.1177/0269881120922950. Epub 2020 May 25.
10
Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg Depression Rating Scale, the gold standard clinician rating scale: A meta-analysis of randomised placebo-controlled trials.新一代抗抑郁药在蒙哥马利-阿斯伯格抑郁评定量表（金标准临床医生评定量表）评估中的疗效：一项随机安慰剂对照试验的荟萃分析。
PLoS One. 2020 Feb 26;15(2):e0229381. doi: 10.1371/journal.pone.0229381. eCollection 2020.